An investigation into KalVista Pharmaceuticals Inc (NASDAQ:KALV)’s technical aspects

In the latest session, KalVista Pharmaceuticals Inc (NASDAQ: KALV) closed at $11.13 down -6.08% from its previous closing price of $11.85. In other words, the price has decreased by -$0.72 from its previous closing price. On the day, 514077 shares were traded. Ratios: For a deeper understanding of KalVista Pharmaceuticals Inc’s stock, let’s take a […]

KalVista Pharmaceuticals Inc (KALV) Stock Price Fluctuations: Highs and Lows

In the latest session, KalVista Pharmaceuticals Inc (NASDAQ: KALV) closed at $11.93 down -4.02% from its previous closing price of $12.43. In other words, the price has decreased by -$0.50 from its previous closing price. On the day, 792470 shares were traded. Ratios: For a deeper understanding of KalVista Pharmaceuticals Inc’s stock, let’s take a […]

Analysts predict high and low EPS estimates for KalVista Pharmaceuticals Inc (KALV)

In the latest session, KalVista Pharmaceuticals Inc (NASDAQ: KALV) closed at $13.10 down -8.77% from its previous closing price of $14.36. In other words, the price has decreased by -$1.26 from its previous closing price. On the day, 664508 shares were traded. Ratios: For a deeper understanding of KalVista Pharmaceuticals Inc’s stock, let’s take a […]

KalVista Pharmaceuticals Inc (KALV) Beta and Market Comparison: S&P500 vs KALV

After finishing at $12.58 in the prior trading day, KalVista Pharmaceuticals Inc (NASDAQ: KALV) closed at $13.69, up 8.82%. In other words, the price has increased by $+1.11 from its previous closing price. On the day, 963038 shares were traded. Ratios: Our goal is to gain a better understanding of KALV by taking a closer […]

KalVista Pharmaceuticals Inc (KALV) stock: EPS estimates from a range of analysts

In other words, the price has increased by $0.00 from its previous closing price. On the day, 1208325 shares were traded. Ratios: Our analysis of KALV’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.25 and its Current Ratio is at […]

KalVista Pharmaceuticals Inc (KALV) Beta: Monthly Comparison and Analysis

KalVista Pharmaceuticals Inc (NASDAQ: KALV) closed the day trading at $13.80 down -7.13% from the previous closing price of $14.86. In other words, the price has decreased by -$1.06 from its previous closing price. On the day, 1384694 shares were traded. KALV stock price reached its highest trading level at $14.78 during the session, while […]

KalVista Pharmaceuticals Inc (KALV)’s financial ratios: A comprehensive overview

After finishing at $14.76 in the prior trading day, KalVista Pharmaceuticals Inc (NASDAQ: KALV) closed at $14.86, up 0.68%. In other words, the price has increased by $+0.10 from its previous closing price. On the day, 1209015 shares were traded. Ratios: Our goal is to gain a better understanding of KALV by taking a closer […]

KalVista Pharmaceuticals Inc (KALV)’s financial ratios: A comprehensive overview

After finishing at $14.40 in the prior trading day, KalVista Pharmaceuticals Inc (NASDAQ: KALV) closed at $14.76, up 2.50%. In other words, the price has increased by $+0.36 from its previous closing price. On the day, 7189197 shares were traded. Ratios: Our goal is to gain a better understanding of KALV by taking a closer […]

Understanding KalVista Pharmaceuticals Inc (KALV) through its ratios

In the latest session, KalVista Pharmaceuticals Inc (NASDAQ: KALV) closed at $14.40 down -3.03% from its previous closing price of $14.85. In other words, the price has decreased by -$0.45 from its previous closing price. On the day, 1577097 shares were traded. Ratios: For a deeper understanding of KalVista Pharmaceuticals Inc’s stock, let’s take a […]